SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-166013
Filing Date
2023-06-13
Accepted
2023-06-13 16:01:54
Documents
18
Period of Report
2023-06-09
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d516259d8k.htm   iXBRL 8-K 41259
2 EX-10.1 d516259dex101.htm EX-10.1 51452
3 EX-10.2 d516259dex102.htm EX-10.2 162454
4 EX-10.3 d516259dex103.htm EX-10.3 83285
5 EX-99.1 d516259dex991.htm EX-99.1 12952
9 GRAPHIC g516259g0613072013895.jpg GRAPHIC 2709
10 GRAPHIC g516259g97i45.jpg GRAPHIC 9424
  Complete submission text file 0001193125-23-166013.txt   570378

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA meip-20230609.xsd EX-101.SCH 2857
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE meip-20230609_lab.xml EX-101.LAB 17995
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE meip-20230609_pre.xml EX-101.PRE 11266
12 EXTRACTED XBRL INSTANCE DOCUMENT d516259d8k_htm.xml XML 3341
Mailing Address 11455 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130
Business Address 11455 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130 858-369-7100
MEI Pharma, Inc. (Filer) CIK: 0001262104 (see all company filings)

IRS No.: 510407811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 000-50484 | Film No.: 231011248
SIC: 2834 Pharmaceutical Preparations